Macrogenics (MGNX) Other Non-Current Liabilities (2012 - 2026)

Macrogenics' (MGNX) quarterly Other Non-Current Liabilities came in at $727000.0 in Q1 2026, down 63.06% year-on-year from $2.0 million in Q1 2025, and down 30.89% on a QoQ basis from $1.1 million in Q4 2025.

Macrogenics (MGNX) Other Non-Current Liabilities (2012 - 2026) Analysis & Trends

Macrogenics (MGNX) has 10 years of Other Non-Current Liabilities data on file, last reported at $727000.0 in Q1 2026.

  • On a quarterly basis, Other Non-Current Liabilities fell 63.06% year-over-year to $727000.0 in Q1 2026; TTM through Mar 2026 was $727000.0, a 63.06% decrease from a year earlier, with the FY2025 full-year figure at $1.1 million, down 46.54% from the prior year.
  • Other Non-Current Liabilities for Q1 2026 stood at $727000.0, down from $1.1 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for MGNX reached as high as $2.0 million in Q4 2024 and fell as low as $258000.0 in Q1 2022.
  • Historically, Other Non-Current Liabilities has averaged $679352.9 across 5 years, with a median of $258000.0 in 2022.
  • Across the five-year window, Other Non-Current Liabilities soared 662.79% in 2024 and tumbled 63.06% in 2026, its largest moves.
  • Year by year, Other Non-Current Liabilities stood at $258000.0 in 2022, then changed by 0.0% to $258000.0 in 2023, then surged by 662.79% to $2.0 million in 2024, then slumped by 46.54% to $1.1 million in 2025, then slumped by 30.89% to $727000.0 in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $727000.0 in Q1 2026, $1.1 million in Q4 2025, and $1.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Macrogenics 254.43 Mn 187.92 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 727,000.00
Dec 31, 2025 1.05 Mn
Sep 30, 2025 1.33 Mn
Jun 30, 2025 1.67 Mn
Mar 31, 2025 1.97 Mn
Dec 31, 2024 1.97 Mn
Sep 30, 2024 258,000.00
Jun 30, 2024 258,000.00
Mar 31, 2024 258,000.00
Dec 31, 2023 258,000.00
Sep 30, 2023 258,000.00
Jun 30, 2023 258,000.00
Mar 31, 2023 258,000.00
Dec 31, 2022 258,000.00
Sep 30, 2022 258,000.00
Jun 30, 2022 258,000.00
Mar 31, 2022 258,000.00
Dec 31, 2021 258,000.00
Sep 30, 2021 258,000.00
Jun 30, 2021 258,000.00